| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| AbbVie has demonstrated strong growth in its immunology sales, highlighting its effective product development strategies and a keen focus on innovation within a competitive market. The company's ability to develop and launch successful therapies underscores its commitment to addressing unmet medical needs. With a robust pipeline and strategic investments, AbbVie continues to leverage its expertise to enhance its product offerings. This proactive approach positions the company favorably for sustained growth and market relevance. |
| The price action of ABBVIE INC (ABBV) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.7 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for ABBV since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.7, and the negative at 0 on 2025-11-26. The forces of and () will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), Valuation Sentiment (0.7), and Sentiment towards Fundamentals (3.3) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| ABBV | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-26 | 0%(0%) | 0 | 0% | 0.7 | 3.3 | -1 | |||||||
| 2025-11-25 | 0%(0%) | 0 | 0% | 0.7 | 3.5 | -1 | |||||||
| 2025-11-24 | 0%(0%) | 0 | 0% | 0.7 | 3.8 | -1 | |||||||
| 2025-11-23 | 0%(0%) | 0 | 0% | 0.8 | 3.4 | -1 | |||||||
| 2025-11-22 | 0%(0%) | 0 | 0% | 0.8 | 3.1 | -1 | |||||||
| 2025-11-21 | 0%(0%) | 0 | 0% | 0.5 | 3.5 | -1 | |||||||
| 2025-11-20 | 0%(0%) | 0 | 0% | 0.1 | 1.2 | -1 | |||||||
| 2025-11-19 | 0%(0%) | 0 | 0% | 0.2 | 1.4 | -1 | |||||||
| 2025-11-18 | 0%(0%) | 0 | 0% | 0.2 | 1.8 | -1 | |||||||
| 2025-11-17 | 0%(0%) | 0 | 0% | 0.3 | 1.2 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-11-26 17:03:33 The upcoming regulatory changes in 2026 may have significant implications for both AbbVie and Pfizer's future operations and sales strategies. |
| 2025-11-26 17:03:33 The company's financial performance, particularly in terms of earnings from immunology sales, reflects a positive trend despite market fluctuations. |
| 2025-11-26 17:03:33 AbbVie's growth in immunology sales points to successful product development and strategic focus in a competitive landscape. |
| 2025-11-26 17:03:33 AbbVie and Pfizer are competing heavily in the pharmaceutical market, particularly in the immunology space, highlighting their positions as industry leaders. |
| 2025-11-26 17:03:33 The recent drop in AbbVie Inc.'s stock price indicates negative sentiment in the market regarding its current performance. |